Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
Authors: Fehrenbacher, Louis | Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology | March 20, 2023 | PubMed abstract
